I agree. Questions were submitted regarded any potential partnerships and LP did not answer them. She briefly glossed over a combo trial proposal that they found unfavorable and did not pursue. Either there has been no discussions with BP or LP just decided to avoid answering those questions. I believe partnerships will be forthcoming and discussions are underway. Previously, I thought they would be for Direct and or prostate. I’m backing away from that and, instead, believe they will be for L for indications other than GBM. Manufacturing will be a prerequisite to any deal. I think we’re only a few weeks away from that. We should see some exciting news the 1st half of next year.